[1] CLIFT A K, KIDD M, BODEI L, et al. Neuroendocrine neoplasms of the small bowel and pancreas[J]. Neuroendocrinology, 2020, 110(6):444-476. [2] WHO Classification of Tumours Editorial Board. Digestive system tumours. WHO classification of tumours [M]. 5th ed. Geneva: WHO, 2019:16. [3] YOU Y, JANG J Y, KIM S C, et al. Validation of the 8th AJCC cancer staging system for pancreas neuroendocrine tumors using Korean Nationwide Surgery Database [J]. Cancer Res Treat, 2019, 51(4):1639-1652. [4] ZHANG X F, XUE F, WU Z, et al. Development and validation of a Modified Eighth AJCC Staging System for Primary pancreatic neuroendocrine tumors[J]. Ann Surg, 2022, 275(6):e773-e780. [5] CIVES M, STROSBERG J R. Gastroenteropancreatic neuroendocrine tumors[J]. CA Cancer J Clin, 2018, 68(6): 471-487. [6] GORELIK M, AHMAD M, GROSSMAN D, et al. Nonfunctioning incidental pancreatic neuroendocrine tumors: who, when, and how to treat?[J]. Surg Clin North Am, 2018, 98(1):157-167. [7] ITO T, IGARASHI H, NAKAMURA K, et al. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis[J]. J Gastroenterol, 2015, 50(1):58-64. [8] SUGIMOTO M, TAKAGI T, HIKICHI T, et al. Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading[J]. World J Gastroenterol, 2015, 21(26):8118-8124. [9] SALLINEN V, LE LARGE T Y, GALEEV S, et al. Surveillance strategy for small asymptomatic non-functional pancreatic neuroendocrine tumors - a systematic review and meta-analysis[J]. HPB:Oxford, 2017, 19(4): 310-320. [10] 周雨,陈洛海,李德智,等. 小非功能性胰腺神经内分泌肿瘤的预后因素[J]. 中华消化杂志,2018,38(3):187-191. |